Items where authors include "Minassian, A.M."
Up a levelArticle
Nielsen, C.M. orcid.org/0000-0002-9033-1318, Barrett, J.R. orcid.org/0000-0003-0746-1945, Davis, C. orcid.org/0000-0002-5022-2838 et al. (22 more authors) (2023) Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine. JCI Insight, 8 (2). e163859. ISSN 2379-3708
de Graaf, H., Payne, R.O. orcid.org/0000-0002-8490-671X, Taylor, I. et al. (25 more authors) (2021) Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial. Frontiers in Immunology, 12. 694759.
Minassian, A.M., Silk, S.E., Barrett, J.R. et al. (47 more authors) (2021) Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination. Med, 2 (6). 701-719.e19. ISSN 2666-6340
Nielsen, C.M., Ogbe, A., Pedroza-Pacheco, I. et al. (17 more authors) (2021) Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors. Cell Reports Medicine, 2 (3). 100207. ISSN 2666-3791
Milne, K., Ivens, A., Reid, A.J. et al. (18 more authors) (2021) Mapping immune variation and var gene switching in naive hosts infected with Plasmodium falciparum. eLife, 10. e62800. ISSN 2050-084X
Ramasamy, M.N., Minassian, A.M., Ewer, K.J. et al. (418 more authors) (2020) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet, 396 (10267). pp. 1979-1993. ISSN 0140-6736
Rawlinson, T.A., Barber, N.M., Mohring, F. et al. (18 more authors) (2019) Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody. Nature Microbiology, 4 (9). pp. 1497-1507. ISSN 2058-5276
Jin, J., Tarrant, R.D., Bolam, E.J. et al. (29 more authors) (2018) Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells. npj Vaccines, 3 (1).
Payne, RO orcid.org/0000-0002-8490-671X, Silk, SE, Elias, SC et al. (39 more authors) (2017) Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. JCI insight, 2 (21). e96381. ISSN 2379-3708